Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William J Watkins

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Scientific Reports|August 14, 2021
miR-141 mediates recovery from acute kidney injuryLucy J Newbury, Kate Simpson, Usman Khalid, et al.
Nature Microbiology|September 28, 2021
A role for arthropods as vectors of multidrug-resistant Enterobacterales in surgical site infections from South AsiaBrekhna Hassan, Muhammad Ijaz, Asadullah Khan, et al.
Plos One|January 14, 2014
Structural and regulatory elements of HCV NS5B polymerase--β-loop and C-terminal tail--are required for activity of allosteric thumb site II inhibitorsSarah E Boyce, Neeraj Tirunagari, Anita Niedziela-Majka, et al.
Molecular Neurodegeneration|June 26, 2016
Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementiaChristopher J Holler, Georgia Taylor, Zachary T McEachin, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2003
The relationship between physicochemical properties, in vitro activity and pharmacokinetic profiles of analogues of diamine-containing efflux pump inhibitorsWilliam J Watkins, Yakira Landaverry, Roger Léger, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2006
Phosphonic acid-containing analogues of mycophenolic acid as inhibitors of IMPDHWilliam J Watkins, James M Chen, Aesop Cho, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2003
MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 2: achieving activity in vivo through the use of alternative scaffoldsKiyoshi Nakayama, Yohei Ishida, Masami Ohtsuka, et al.
Biomedicines|January 13, 2021
The Non-Steroidal FXR Agonist Cilofexor Improves Portal Hypertension and Reduces Hepatic Fibrosis in a Rat NASH ModelPhilipp Schwabl, Eva Hambruch, Grant R Budas, et al.
Cancer Immunology Research|October 7, 2020
Immune Remodeling of the Extracellular Matrix Drives Loss of Cancer Stem Cells and Tumor RejectionAna Pires, Alexander Greenshields-Watson, Emma Jones, et al.
Bioorganic & Medicinal Chemistry|September 18, 2007
MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 7: highly soluble and in vivo active quaternary ammonium analogue D13-9001, a potential preclinical candidateKen-Ichi Yoshida, Kiyoshi Nakayama, Masami Ohtsuka, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Scientific Reports|August 14, 2021
miR-141 mediates recovery from acute kidney injuryLucy J Newbury, Kate Simpson, Usman Khalid, et al.
Nature Microbiology|September 28, 2021
A role for arthropods as vectors of multidrug-resistant Enterobacterales in surgical site infections from South AsiaBrekhna Hassan, Muhammad Ijaz, Asadullah Khan, et al.
Plos One|January 14, 2014
Structural and regulatory elements of HCV NS5B polymerase--β-loop and C-terminal tail--are required for activity of allosteric thumb site II inhibitorsSarah E Boyce, Neeraj Tirunagari, Anita Niedziela-Majka, et al.
Molecular Neurodegeneration|June 26, 2016
Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementiaChristopher J Holler, Georgia Taylor, Zachary T McEachin, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2003
The relationship between physicochemical properties, in vitro activity and pharmacokinetic profiles of analogues of diamine-containing efflux pump inhibitorsWilliam J Watkins, Yakira Landaverry, Roger Léger, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2006
Phosphonic acid-containing analogues of mycophenolic acid as inhibitors of IMPDHWilliam J Watkins, James M Chen, Aesop Cho, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2003
MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 2: achieving activity in vivo through the use of alternative scaffoldsKiyoshi Nakayama, Yohei Ishida, Masami Ohtsuka, et al.
Biomedicines|January 13, 2021
The Non-Steroidal FXR Agonist Cilofexor Improves Portal Hypertension and Reduces Hepatic Fibrosis in a Rat NASH ModelPhilipp Schwabl, Eva Hambruch, Grant R Budas, et al.
Cancer Immunology Research|October 7, 2020
Immune Remodeling of the Extracellular Matrix Drives Loss of Cancer Stem Cells and Tumor RejectionAna Pires, Alexander Greenshields-Watson, Emma Jones, et al.
Bioorganic & Medicinal Chemistry|September 18, 2007
MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 7: highly soluble and in vivo active quaternary ammonium analogue D13-9001, a potential preclinical candidateKen-Ichi Yoshida, Kiyoshi Nakayama, Masami Ohtsuka, et al.
Pageof 5